Page last updated: 2024-10-20
pyridoxamine and Angiogenesis, Pathologic
pyridoxamine has been researched along with Angiogenesis, Pathologic in 2 studies
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Early diabetic retinopathy is characterized by a loss of pericytes from retinal capillaries, the appearance of acellular capillaries and microaneurysms, and a breakdown of the blood-retinal barrier." | 2.49 | Advanced glycation end products and diabetic retinopathy. ( Brownstein, S; Milne, R, 2013) |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Milne, R | 1 |
| Brownstein, S | 1 |
| Matsubara, K | 1 |
| Mori, M | 1 |
| Akagi, R | 1 |
| Kato, N | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| The Relationship of Advanced Glycation Endproducts in the Anterior Lens Capsule to Glycemic Status and Diabetic Retinopathy: A Cross Sectional Study of Patients With and Without Type 2 Diabetes Mellitus Undergoing Cataract Surgery[NCT02662010] | | 157 participants (Actual) | Observational | 2016-03-31 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Reviews
1 review available for pyridoxamine and Angiogenesis, Pathologic
Other Studies
1 other study available for pyridoxamine and Angiogenesis, Pathologic